likewise
,
cpsc
reports
that
,
based
upon
data
from
its
national
electronic
injury
surveillance
system
(
neiss
)
(
neiss
is
a
probability
sample
of
hospital
emergency
rooms
in
the
united
states
that
is
used
by
the
cpsc
to
measure
the
magnitude
of
the
injury
problem
associated
with
consumer
products
and
to
provide
a
source
for
followup
investigations
of
selected
cases
,
there
was
a
significant
upward
trend
in
the
estimated
number
of
hospital
emergency
roomtreated
room
treated
iron
ingestion
cases
involving
children
under
5
years
of
age
in
the
1980
to
1993
period
.
every
annual
estimate
in
the
1980
to
1985
period
was
smaller
than
every
annual
estimate
in
the
1986
to
1993
period
.
the
estimated
average
number
of
cases
annually
was
1240
for
the
1980
to
1985
period
and
3170
for
the
1986
to
1993
period
(
ref
.
1
.
2
.
cpsc
case
reports
cpsc
considers
ironcontaining
iron
containing
products
to
be
potentially
hazardous
to
children
and
,
thus
,
has
taken
a
number
of
significant
steps
designed
to
reduce
the
risk
from
these
products
.
as
part
of
its
efforts
,
cpsc
has
collected
detailed
information
on
pediatric
iron
poisoning
fatalities
and
has
also
conducted
followup
(
from
neiss
data
)
investigations
of
incidents
of
nonfatal
pediatric
iron
ingestion
where
the
victim
was
taken
to
a
hospital
emergency
room
.
in
order
to
evaluate
the
available
data
on
specific
occurrences
of
iron
poisoning
as
fully
as
possible
,
fda
obtained
from
cpsc
the
case
reports
on
37
fatal
pediatric
poisonings
(
ref
.
21
)
and
on
70
neiss
followup
investigations
of
nonfatal
pediatric
iron
ingestions
for
the
years
1986
to
1993
(
ref
.
22
.
these
data
are
described
below
and
are
summarized
in
tables
4
and
5
.
table
4
summarizes
the
data
obtained
from
cpsc
on
37
iron
poisoning
fatalities
of
young
children
since
1986
.
among
these
fatalities
,
the
average
age
of
the
victim
was
168
months
.
in
25
of
these
37
deaths
,
the
iron
potency
of
the
implicated
product
was
reported
.
these
25
products
contained
,
on
average
,
63
mg
iron
per
dosage
unit
.
the
lowest
reported
potency
of
an
ironcontaining
iron
containing
product
involved
in
these
pediatric
deaths
was
40
mg
iron
per
dosage
unit
.
the
potency
of
the
ironcontaining
iron
containing
product
involved
in
the
12
other
deaths
was
not
reported
.
table
4
shows
that
,
in
21
of
the
37
fatalities
,
information
on
the
number
of
tablets
or
capsules
consumed
by
the
victim
was
reported
.
among
these
21
reports
,
the
average
number
of
iron
tablets
or
capsules
consumed
by
the
victim
was
39
.
table
4
also
shows
that
in
56
percent
of
these
37
pediatric
deaths
(
21/37
,
the
ironcontaining
iron
containing
product
visually
appeared
to
be
packaged
in
childresistant
child
resistant
packaging
(
crp
,
and
more
specifically
,
in
containers
with
apparently
childresistant
child
resistant
closures
(
crc
.
in
16
percent
of
the
deaths
(
6/37
,
the
ironcontaining
iron
containing
supplement
was
not
packaged
in
crp
.
among
the
remaining
deaths
(
10/37
,
the
type
of
packaging
was
not
reported
.
<
text
>
